Explore our flagship electrophoresis instruments โ engineered for precision hemoglobin separation and clinical diagnostics, fully compliant with international laboratory standards.
Austria stands at the forefront of European life science innovation, with a thriving biomedical industry that demands the highest standards in hemoglobin analysis and clinical laboratory equipment.
Austria operates one of Europe's most advanced healthcare systems, with over 270 public and private hospitals, numerous specialized hematology centers, and university medical facilities that rely on Hb electrophoresis systems for routine diagnostics and hemoglobinopathy screening.
Renowned institutions including the Medical University of Vienna, Graz Medical University, and the Austrian Academy of Sciences actively use electrophoresis technology for cutting-edge research in proteomics, genomics, and molecular biology โ driving steady demand for advanced systems.
As an EU member, Austria serves as a strategic entry point for life science equipment across Central and Eastern Europe. Manufacturers supplying Hb electrophoresis systems to Austria benefit from CE certification access and streamlined distribution throughout the broader European market.
Hb electrophoresis systems serve a wide range of critical applications across Austria's healthcare and scientific ecosystem.
Austrian hospitals and newborn screening programs utilize Hb electrophoresis for the early detection of sickle cell disease, beta-thalassemia, and other hemoglobin variants. This is especially relevant given Austria's multicultural population and migration-driven increases in hemoglobinopathy prevalence in urban centers like Vienna.
Certified Austrian medical laboratories (Sanitรคtsbehรถrden) employ electrophoresis systems for HbA1c quantification, anemia diagnosis, and protein separation workflows. These labs demand instruments with superior reproducibility, digital data integration, and CE-certified accuracy.
Austrian universities including TU Wien and the University of Innsbruck integrate Hb electrophoresis into biochemistry, molecular biology, and life science curricula. Advanced systems support student training and faculty research in proteomics, disease modeling, and therapeutic development.
Austria's pharmaceutical industry โ home to companies like Boehringer Ingelheim Regional Center Vienna and Octapharma โ uses electrophoresis systems in protein purity analysis, biopharmaceutical characterization, and quality control processes aligned with EMA regulatory frameworks.
Austria's active sports science sector โ supported by the Austrian Anti-Doping Federal Law โ uses advanced electrophoresis for blood doping detection and HbF/HbA ratio analysis, making high-resolution Hb electrophoresis an essential tool for certified sports medicine laboratories.
Prenatal care centers and genetic counseling clinics across Austria rely on Hb electrophoresis for carrier screening in families with known hemoglobinopathy risks. These applications require ultra-sensitive separation capabilities and CE-marked instrumentation aligned with Austrian medical device regulations (MPG).
The global and European Hb electrophoresis market is evolving rapidly, shaped by technological innovation, regulatory shifts, and increasing clinical demands.
Next-generation electrophoresis systems now integrate artificial intelligence for automated band detection, quantification, and result interpretation. AI-powered gel image analysis significantly reduces manual labor, eliminates human error, and accelerates diagnostic turnaround times in high-throughput Austrian clinical laboratories.
Modern Hb electrophoresis systems are increasingly LIS (Laboratory Information System) compatible, enabling seamless data transfer, remote monitoring, and workflow automation. This trend aligns with Austria's digital health strategy (eHealth Austria) and EU digital laboratory initiatives.
With Austria's strong environmental commitments and EU Green Deal objectives, manufacturers are developing electrophoresis systems with reduced reagent consumption, energy-efficient power supplies, and recyclable materials โ meeting Austrian environmental standards (UVP) while maintaining superior analytical performance.
The trend toward compact, modular electrophoresis platforms โ capable of processing multiple gel runs simultaneously โ is transforming Austrian diagnostic labs. Miniaturized systems like the DYCZ-24DN series offer full analytical capability in a fraction of the bench space, ideal for space-constrained hospital laboratories.
Beijing Liuyi Biotechnology Co., Ltd., formerly known as Beijing Liuyi Instrument Factory, established in 1970, is a national high technology enterprise with a long history. It is a leading and the biggest manufacturer in electrophoresis instrument for life science laboratories in China.
Based on the life science and biotechnology industries, our main products always remain at the domestic industry leading position and are well-known in the industry, exported to other countries and areas. We have our own R&D team, open to scientific research innovation, market development first, industry and combined with the development, the economic scale of our company have rapid growth for several years.
Our products are trusted by research institutions, hospitals, pharmaceutical companies, and universities across more than 30 countries โ including Austria, Germany, the United Kingdom, the United States, Brazil, India, Singapore, and beyond.
Liuyi has specialized in manufacturing electrophoresis instruments for more than 50 years with our own professional technical team and R&D center. We have reliable and complete production lines from design to inspection, warehousing, as well as marketing support.
Our main products are Electrophoresis Cell (tank/chamber), Electrophoresis Power Supply, Blu LED Transilluminator, UV Transilluminator, and Gel Image & Analysis System. According to your requirements, we can provide fully customized service for your laboratory needs.
Our engineering team stays current with IVD regulatory requirements across the EU, ensuring every Hb electrophoresis system we manufacture meets CE certification standards and is optimized for integration into Austrian and European clinical workflows.
Liuyi has been awarded a variety of certificates and enterprise qualifications along with its high reputation in the industry. We are ISO 9001 & ISO 13485 certified company and some of our products have CE certificates. Since 2003, Liuyi as the only medical device manufacturer in Beijing medical industry has been awarded as "PROMISE-KEEPING ENTERPRISE" by Beijing Administration for Industry and Commerce.
In 2008, Liuyi is honored as the famous trademark of Beijing. Our trademark is under the protection of Madrid Protocol in 7 countries including the United States, the United Kingdom, Japan, South Korea, Singapore, Greece, and Zambia in 2005, as well as registered trademark in India and Vietnam.
Beijing Liuyi Biotechnology Co., Ltd has launched new products for protein analysis, western blotting and gel observation. DYCZ-MINI series are fully compatible with the main international brands, and can run up to four precast or handcast polyacrylamide gels. The trans-blot module of DYCZ-TRANS2 is compatible with the chamber of DYCZ-MINI series. The WD-9403B can observe gel for nucleic acid electrophoresis. These new products are all durable, versatile, and easy to assemble. Welcome to contact us for more details!
A comprehensive range of electrophoresis instruments and accessories designed to support every stage of hemoglobin analysis, nucleic acid separation, and molecular diagnostics.
With over 50 years of innovation, ISO-certified manufacturing, and a global distribution network, Beijing Liuyi Biotechnology is your ideal partner for precision electrophoresis solutions in Austria and across Europe. Contact us today to discuss your specific laboratory requirements.